80 FR 35965 - Center for Scientific Review; Notice of Closed Meetings.

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 120 (June 23, 2015)

Page Range		35965-35966
FR Document		2015-15308

Federal Register, Volume 80 Issue 120 (Tuesday, June 23, 2015)

[Federal Register Volume 80, Number 120 (Tuesday, June 23, 2015)]
[Notices]
[Pages 35965-35966]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-15308]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings.

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Endocrinology, Metabolism, Nutrition and 
Reproductive Sciences.
    Date: July 14, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Dianne Hardy, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6175, MSC 7892, Bethesda, MD 20892, 301-435-
1154, dianne.hardy@nih.gov.

    Name of Committee: AIDS and Related Research Integrated Review 
Group; NeuroAIDS and other End-Organ Diseases Study Section.
    Date: July 23, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Eduardo A Montalvo, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5108,

[[Page 35966]]

MSC 7852, Bethesda, MD 20892, (301) 435-1168, montalve@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-13-327: Innovative Molecular Analysis Technology 
Development for Cancer Research and Clinical Care.
    Date: July 23, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Zhang-Zhi Hu, MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6186, MSC 7804, Bethesda, MD 20892, (301) 594-
2414, huzhuang@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Musculoskeletal Rehabilitation.
    Date: July 23, 2015.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for 
Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301-435-1212, 
kumarra@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; FOA: RM15-002 Exploratory Technologies.
    Date: July 24, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Embassy Row Hotel, 2015 Massachusetts Avenue NW., 
Washington, DC 20036.
    Contact Person: Robert C. Elliott, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3130, MSC 7850, Bethesda, MD 
20892, 301-435-3009, elliotro@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Clinical Neuroscience and Neurodegeneration.
    Date: July 24, 2015.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Alessandra C Rovescalli, Ph.D., Scientific 
Review Officer, National Institutes of Health, Center for Scientific 
Review, 6701 Rockledge Drive, Rm 5205 MSC7846, Bethesda, MD 20892, 
(301) 435-1021, rovescaa@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in Bacterial Pathogenesis and Host 
Interactions.
    Date: July 24, 2015.
    Time: 12:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435-
0903, saadisoh@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 17, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-15308 Filed 6-22-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 120 / Tuesday, June 23, 2015 / Notices 35965

continuing applications and foreign bearing and will comply with the terms MD 20892–7968, 301–594–4937, huangz@
counterparts to Absino Co., Ltd, a and conditions of 35 U.S.C. 209 and 37 mail.nih.gov.
company having a place of business in CFR part 404. The prospective start-up (Catalogue of Federal Domestic Assistance
Beijing, China. exclusive evaluation option license may Program No. 93.879, Medical Library
The patent rights in these inventions be granted unless within fifteen (15) Assistance, National Institutes of Health,
have (a) been assigned to the United days from the date of this published HHS)
States of America, as represented by the notice, the NIH receives written Dated: June 17, 2015.
Secretary, Department of Health and evidence and argument that establishes Michelle Trout,
Human Services who has delegated that the grant of the license would not Program Analyst, Office of the Federal
authority for the licensing of inventions be consistent with the requirements of Advisory Committee Policy.
to the National Institutes of Health or (b) 35 U.S.C. 209 and 37 CFR part 404. [FR Doc. 2015–15299 Filed 6–22–15; 8:45 am]
been exclusively licensed to the Applications for a license in the field BILLING CODE 4140–01–P
National Institutes of Health. of use filed in response to this notice
The prospective start-up exclusive will be treated as objections to the grant
evaluation option license territory may of the contemplated start-up exclusive DEPARTMENT OF HEALTH AND
be China, the U.S., and Europe, and the evaluation option license. Comments HUMAN SERVICES
field of use may be limited to the and objections submitted to this notice
development of bispecific multivalent will not be made available for public National Institutes of Health
human immunodeficiency virus type 1 inspection and, to the extent permitted
(HIV–1) neutralizing fusion proteins as by law, will not be released under the Center for Scientific Review; Notice of
HIV entry inhibitors for the treatment of Freedom of Information Act, 5 U.S.C. Closed Meetings.
HIV infections. 552.
Upon the expiration or termination of Pursuant to section 10(d) of the
the start-up exclusive evaluation option Dated: June 16, 2015. Federal Advisory Committee Act, as
license, Absino Co., Ltd will have the Richard U. Rodriguez, amended (5 U.S.C. App.), notice is
exclusive right to execute an exclusive Acting Director, Office of Technology hereby given of the following meetings.
commercialization license which will Transfer, National Institutes of Health. The meetings will be closed to the
supersede and replace the start-up [FR Doc. 2015–15334 Filed 6–22–15; 8:45 am] public in accordance with the
exclusive evaluation option license with BILLING CODE 4140–01–P provisions set forth in sections
no greater field of use and territory than 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
granted in the start-up exclusive as amended. The grant applications and
evaluation option license. DEPARTMENT OF HEALTH AND the discussions could disclose
DATES: Only written comments and/or HUMAN SERVICES confidential trade secrets or commercial
applications for a license which are property such as patentable material,
National Institutes of Health and personal information concerning
received by the NIH Office of
Technology Transfer on or before July 8, National Library of Medicine; Notice of individuals associated with the grant
2015 will be considered. Closed Meeting applications, the disclosure of which
ADDRESSES: Requests for copies of the would constitute a clearly unwarranted
patent application, inquiries, comments, Pursuant to section 10(d) of the invasion of personal privacy.
and other materials relating to the Federal Advisory Committee Act, as Name of Committee: Center for Scientific
contemplated start-up exclusive amended (5 U.S.C. App), notice is Review Special Emphasis Panel;
evaluation option license should be hereby given of the following meeting. Fellowships: Endocrinology, Metabolism,
directed to: Sally Hu, Ph.D., M.B.A., The meeting will be closed to the Nutrition and Reproductive Sciences.
Senior Licensing and Patenting Date: July 14, 2015.
public in accordance with the Time: 8:00 a.m. to 5:00 p.m.
Manager, Office of Technology Transfer, provisions set forth in sections Agenda: To review and evaluate grant
National Institutes of Health, 6011 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
Executive Boulevard, Suite 325, as amended. The grant applications and Place: National Institutes of Health, 6701
Rockville, MD 20852–3804; Telephone: the discussions could disclose Rockledge Drive, Bethesda, MD 20892
(301) 435–5606; Facsimile: (301) 402– confidential trade secrets or commercial (Virtual Meeting).
0220; Email: hus@mail.nih.gov. property such as patentable materials, Contact Person: Dianne Hardy, Ph.D.,
SUPPLEMENTARY INFORMATION: The and personal information concerning Scientific Review Officer, Center for
individuals associated with the grant Scientific Review, National Institutes of
subject technology is HIV–1 entry
Health, 6701 Rockledge Drive, Room 6175,
inhibitors that can neutralize many applications, the disclosure of which MSC 7892, Bethesda, MD 20892, 301–435–
subtypes of HIV–1 isolates including would constitute a clearly unwarranted 1154, dianne.hardy@nih.gov.
clade A–E and tropism R5 and X4 (using invasion of personal privacy. Name of Committee: AIDS and Related
either CCR5 or CXCR4 co-receptor for Name of Committee: National Library of Research Integrated Review Group;
entry). These entry inhibitors are fusion Medicine Special Emphasis Panel; Conflicts NeuroAIDS and other End-Organ Diseases
proteins and have a potency about 10- R01/R21/R13. Study Section.
fold higher than that of the broadly Date: July 30, 2015. Date: July 23, 2015.
neutralizing antibody VRC01 that is in Time: 12:00 p.m. to 4:00 p.m. Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant Agenda: To review and evaluate grant
mstockstill on DSK4VPTVN1PROD with NOTICES

Phase I clinical trial, or 50-fold higher
than that of the FDA approved HIV applications. applications.
Place: National Library of Medicine, 6705 Place: Hyatt Regency Bethesda, One
entry inhibitor Fuzeon. Therefore, these
Rockledge Drive, Suite 301, Bethesda, MD Bethesda Metro Center, 7400 Wisconsin
fusion proteins are promising drug 20817, (Telephone Conference Call). Avenue, Bethesda, MD 20814.
candidates for HIV/AIDS prevention Contact Person: Zoe E. Huang, MD., Contact Person: Eduardo A Montalvo,
and treatment. Scientific Review Officer, Extramural Ph.D., Scientific Review Officer, Center for
The prospective start-up exclusive Programs, National Library of Medicine, NIH, Scientific Review, National Institutes of
evaluation option license will be royalty 6705 Rockledge Drive, Suite 301, Bethesda, Health, 6701 Rockledge Drive, Room 5108,

VerDate Sep<11>2014 18:39 Jun 22, 2015 Jkt 235001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\23JNN1.SGM 23JNN1

35966 Federal Register / Vol. 80, No. 120 / Tuesday, June 23, 2015 / Notices

MSC 7852, Bethesda, MD 20892, (301) 435– Contact Person: Soheyla Saadi, Ph.D., Dated: June 17, 2015.
1168, montalve@csr.nih.gov. Scientific Review Officer, Center for Michelle Trout,
Name of Committee: Center for Scientific Scientific Review, National Institutes of Program Analyst, Office of Federal Advisory
Review Special Emphasis Panel; PAR–13– Health, 6701 Rockledge Drive, Room 3211, Committee Policy.
327: Innovative Molecular Analysis MSC 7808, Bethesda, MD 20892, 301–435–
[FR Doc. 2015–15304 Filed 6–22–15; 8:45 am]
Technology Development for Cancer 0903, saadisoh@csr.nih.gov.
Research and Clinical Care. BILLING CODE 4140–01–P
(Catalogue of Federal Domestic Assistance
Date: July 23, 2015.
Program Nos. 93.306, Comparative Medicine;
Time: 8:00 a.m. to 6:00 p.m.
93.333, Clinical Research, 93.306, 93.333,
Agenda: To review and evaluate grant
applications. 93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National DEPARTMENT OF HOMELAND
Place: National Institutes of Health, 6701 SECURITY
Rockledge Drive, Bethesda, MD 20892 Institutes of Health, HHS)
(Telephone Conference Call). Dated: June 17, 2015. Federal Emergency Management
Contact Person: Zhang-Zhi Hu, MD,
Scientific Review Officer, Center for David Clary, Agency
Scientific Review, National Institutes of Program Analyst, Office of Federal Advisory
Health, 6701 Rockledge Drive, Room 6186, Committee Policy. [Internal Agency Docket No. FEMA–4223–
MSC 7804, Bethesda, MD 20892, (301) 594– [FR Doc. 2015–15308 Filed 6–22–15; 8:45 am] DR; Docket ID FEMA–2015–0002]
2414, huzhuang@csr.nih.gov. BILLING CODE 4140–01–P
Name of Committee: Center for Scientific Texas; Amendment No. 1 to Notice of
Review Special Emphasis Panel; a Major Disaster Declaration
Musculoskeletal Rehabilitation.
DEPARTMENT OF HEALTH AND
Date: July 23, 2015. AGENCY:Federal Emergency
Time: 2:00 p.m. to 5:00 p.m. HUMAN SERVICES
Management Agency, DHS.
Agenda: To review and evaluate grant
applications. National Institutes of Health ACTION: Notice.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892 National Center For Complementary & SUMMARY: This notice amends the notice
(Telephone Conference Call). Integrative Health; Notice of Closed of a major disaster declaration for the
Contact Person: Rajiv Kumar, Ph.D., Chief, Meeting State of Texas (FEMA–4223–DR), dated
MOSS IRG, Center for Scientific Review, May 29, 2015, and related
National Institutes of Health, 6701 Rockledge Pursuant to section 10(d) of the
Drive, Room 4216, MSC 7802, Bethesda, MD
determinations.
Federal Advisory Committee Act, as
20892, 301–435–1212, kumarra@csr.nih.gov. DATES: Effective Date: June 5, 2015.
amended (5 U.S.C. App.), notice is
Name of Committee: Center for Scientific hereby given of the following meeting.
Review Special Emphasis Panel; FOA: FOR FURTHER INFORMATION CONTACT:
RM15–002 Exploratory Technologies. The meeting will be closed to the Dean Webster, Office of Response and
Date: July 24, 2015. public in accordance with the Recovery, Federal Emergency
Time: 8:00 a.m. to 6:00 p.m. provisions set forth in sections Management Agency, 500 C Street SW.,
Agenda: To review and evaluate grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Washington, DC 20472, (202) 646–2833.
applications.
as amended. The grant applications and SUPPLEMENTARY INFORMATION: The notice
Place: The Embassy Row Hotel, 2015
Massachusetts Avenue NW., Washington, DC the discussions could disclose of a major disaster declaration for the
20036. confidential trade secrets or commercial State of Texas is hereby amended to
Contact Person: Robert C. Elliott, Ph.D., property such as patentable material, include the following areas among those
Scientific Review Officer, Center for and personal information concerning areas determined to have been adversely
Scientific Review, National Institutes of individuals associated with the grant affected by the event declared a major
Health, 6701 Rockledge Drive, Room 3130, applications, the disclosure of which
MSC 7850, Bethesda, MD 20892, 301–435– disaster by the President in his
would constitute a clearly unwarranted declaration of May 29, 2015.
3009, elliotro@csr.nih.gov.
invasion of personal privacy.
Name of Committee: Center for Scientific Bastrop, Blanco, Caldwell, Denton,
Review Special Emphasis Panel; Clinical Name of Committee: National Center for Eastland, Fort Bend, Guadalupe, Henderson,
Neuroscience and Neurodegeneration. Complementary and Integrative Health Hidalgo, Johnson, Milam, Montague, Rusk,
Date: July 24, 2015. Special Emphasis Panel; NCCIH Complex Smith, Travis, Wichita, Williamson, and
Time: 8:30 a.m. to 5:00 p.m. Trials. Wise Counties for Individual Assistance.
Agenda: To review and evaluate grant Date: July 13, 2015. Gaines and Navarro Counties for
applications. Time: 1:00 p.m. to 4:00 p.m. Individual Assistance (already designated for
Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant Public Assistance).
Rockledge Drive, Bethesda, MD 20892. applications. The following Catalog of Federal Domestic
Contact Person: Alessandra C Rovescalli, Place: National Institutes of Health, Assistance Numbers (CFDA) are to be used
Ph.D., Scientific Review Officer, National Democracy 2, Suite 401, 6707 Democracy for reporting and drawing funds: 97.030,
Institutes of Health, Center for Scientific Boulevard, Bethesda, MD 20892 (Telephone Community Disaster Loans; 97.031, Cora
Review, 6701 Rockledge Drive, Rm 5205 Conference Call). Brown Fund; 97.032, Crisis Counseling;
MSC7846, Bethesda, MD 20892, (301) 435– 97.033, Disaster Legal Services; 97.034,
Contact Person: Hungyi Shau, Ph.D.,
1021, rovescaa@mail.nih.gov. Disaster Unemployment Assistance (DUA);
Scientific Review Officer, National Center for
Name of Committee: Center for Scientific Complementary and Integrative Health, 97.046, Fire Management Assistance Grant;
97.048, Disaster Housing Assistance to
mstockstill on DSK4VPTVN1PROD with NOTICES

Review Special Emphasis Panel; Member National Institutes of Health, 6707
Conflict: Topics in Bacterial Pathogenesis Individuals and Households In Presidentially
Democracy Boulevard, Suite 401, Bethesda,
and Host Interactions. Declared Disaster Areas; 97.049,
MD 20892, 301–402–1030, Hungyi.Shau@ Presidentially Declared Disaster Assistance—
Date: July 24, 2015.
Time: 12:00 p.m. to 6:00 p.m. nih.gov. Disaster Housing Operations for Individuals
Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance and Households; 97.050 Presidentially
applications. Program Nos. 93.213, Research and Training Declared Disaster Assistance to Individuals
Place: National Institutes of Health, 6701 in Complementary and Alternative Medicine, and Households—Other Needs; 97.036,
Rockledge Drive, Bethesda, MD 20892. National Institutes of Health, HHS) Disaster Grants—Public Assistance

VerDate Sep<11>2014 18:39 Jun 22, 2015 Jkt 235001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\23JNN1.SGM 23JNN1

Document Created: 2018-02-22 11:15:25
Document Modified: 2018-02-22 11:15:25

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 14, 2015.
FR Citation		80 FR 35965

80 FR 35965 - Center for Scientific Review; Notice of Closed Meetings.

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 120 (June 23, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health